Skip to main content
Caplight Logo









ProtonDx

ProtonDx

Private
LondonHealthcare & Life Scienceshttps://www.protondx.com/

Last Round

Seed

Dec 4, 2025

Total Funding Raised

$4.58M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ProtonDx is a diagnostic equipment company that develops a portable molecular diagnostic platform designed to deliver rapid, laboratory-grade testing at the point of need.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

molecular diagnosticspoint of care testingrapid diagnosticsPOCTlab on a chipportable diagnosticsanimal health diagnosticsinfectious disease testingLAMP testingisothermal amplificationveterinary diagnosticsdiagnostic equipmentnucleic acid extractionagritech diagnosticsresearch use onlyRUOrazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProtonDx Comparables

Compare ProtonDx with similar companies based on industry and business-model similarity.

ProtonDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alveo Technologies
88%
Llusern Scientific
85%
QuidelOrtho
84%

ProtonDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 4, 2025
GrantJun 25, 2025
GrantFeb 18, 2025
GrantSep 28, 2022

Key People

Founding team and executive leadership

Jesus Rodriguez Manzano

Co-Founder and Chief Scientific Officer

Founding Team

Nick Moser

Co-Founder and Chief Technology Officer

Founding Team

Pantelis Georgiou

Co-Founder & CEO

Founding Team

Pierre S.

Chief Financial Officer

Executive Team

ProtonDx Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 111% MoM.

  • Dec 8, 2025

    Monthly visitors grew 897% MoM, from 370 to 3.7K.

ProtonDx Filings

Explore SEC and related filing metadata, where available.

ProtonDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ProtonDx's valuation, stock price, and market status.

Is ProtonDx a public or private company?

ProtonDx is a private company.

What is the current stock price of ProtonDx?

ProtonDx is a private company with no public stock price. No recent secondary market data is available.

How much is ProtonDx worth (valuation)?

Valuation information for ProtonDx is not publicly available.

Can I buy ProtonDx stock?

ProtonDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ProtonDx's last funding round?

ProtonDx's most recent funding round was Seed on December 4, 2025.

Who are the main investors in ProtonDx?

Key investors in ProtonDx include CARB-X, SBRI Healthcare, Innovate UK, Department for Environment, Food & Rural Affairs.

Will ProtonDx IPO soon?

No public IPO plans have been announced for ProtonDx.

How can I track ProtonDx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ProtonDx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range27
Year Founded2020
Last FundingDec 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?